Clinical trial
Evaluation of the Safety and Performance of the Multilayer Flow Modulator (MFM) for the Treatment of Chronic Type B Aortic Dissection
NCT03033771 is registered in ClinicalTrials.gov with Cardiatis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Performance of the Multilayer Flow Modulator (MFM) for the Treatment of Chronic Type B Aortic Dissection
- Lead sponsor
- Cardiatis
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 31, 2016
- Completion date
- December 31, 2029
- Enrollment
- 27 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
aortic dissection type b